Covetrus (CVET) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 20 253 sessions, October 12, 2021 to October 12, 2022
- Largest daily move
- +10.5% close of May 6, 2022
- 1-year change
- +13.3% closing prices, October 12, 2021 to October 12, 2022
Company Description
Covetrus Inc. is a global animal-health technology and services company that provides products, services, and technology for veterinary practices. The company describes its operating model as a single platform that connects veterinary practice partners with solutions and insights used in animal care and practice operations. Covetrus is headquartered in Portland, Maine, and its historical public-company ticker was CVET on Nasdaq.
The company’s business is centered on the veterinary community. Its offerings include animal-health products, practice services, prescription management capabilities, proprietary brands, and technology tools that support veterinarians, their practices, and patients. Covetrus has described its mission in terms of improving health and financial outcomes for veterinary practice partners by combining distribution, services, and technology into an integrated platform.
As a public company, Covetrus reported activity across geographic operating areas that included North America, Europe, and APAC & Emerging Markets. Company updates referenced demand for prescription management, adoption of its technology stack, growth of proprietary brands, and management of corporate costs as recurring operating themes. Its customer base and operating focus were global, with veterinary practices as the core end market.
The CVET ticker also represents a completed corporate-status history. Former holders of Covetrus common stock had their shares exchanged for cash on October 13, 2022, and later stockholder litigation materials referenced those former holders and the exchange of Covetrus securities. Subsequent company announcements continued to describe Covetrus as an animal-health technology and services company, while the CVET symbol remains a historical reference to the company’s former Nasdaq-listed public equity.
Stock Performance
Covetrus (CVET) closed at $20.99 on October 12, 2022. Over the past 12 months, the price has gained 13.3%.
CVET Metrics & Rankings
Price returns through October 12, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Covetrus has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include management, earnings, acquisition. View all CVET news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CVET Company Profile & Sector Positioning
Covetrus (CVET) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CVET often look at related companies in the same sector, including Henry Schein Inc (HSIC), Clinigen Group (CGNGY), Akso Health Group ADS (AHG), Owens & Minor, Inc. (OMI), and Cencora, Inc. (COR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CVET's relative position within its industry.